Migraine with comorbid fibromyalgia: psychological burden and impact on frequency and severity of migraine attacks - Takeaways - MDSpire

Migraine with comorbid fibromyalgia: psychological burden and impact on frequency and severity of migraine attacks

  • By

  • Amr Hassan

  • Mona Hussein

  • Rehab Magdy

  • Anas Elgenidi

  • Nahla Merghany

  • Ahmed Yehia Ismaeel

  • Mohamed Abdelghaffar

  • Osama Yacoub

  • May M. Fayez

  • Nourhan Abdelmohsen Taha

  • Ramez Reda Moustafa

  • Ahmed Essmat

  • April 30, 2026

  • 0 min

Share

  • 1

    Fibromyalgia significantly increases the frequency and severity of migraine attacks in patients with comorbid conditions.

  • 2

    Patients with both fibromyalgia and migraine report higher psychological burdens, as indicated by elevated DASS-12 scores.

  • 3

    A positive correlation exists between the severity of fibromyalgia symptoms and both migraine frequency and psychological distress.

  • 4

    The study highlights the need for multidisciplinary management strategies targeting both migraine and fibromyalgia.

  • 5

    Accurate diagnosis of fibromyalgia in migraine patients is crucial for effective treatment and improved quality of life.

Original Source(s)

Migraine with comorbid fibromyalgia: psychological burden and impact on frequency and severity of migraine attacks

  • by Amr Hassan, Mona Hussein, Rehab Magdy, Anas Elgenidi, Nahla Merghany, Ahmed Yehia Ismaeel, Mohamed Abdelghaffar, Osama Yacoub, May M. Fayez, Nourhan Abdelmohsen Taha, Ramez Reda Moustafa, Ahmed Essmat

  • April 30, 2026

Related Content

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Sleep Apnea’s Billion-Dollar Toll

New analysis links untreated OSA to major productivity losses in working-age adults in the US and UK